Change in the regulatory framework for zolpidem

In recent years, zolpidem has been the subject of numerous reports of misuse, abuse and dependence. In view of these risks, the French drug agency (ANSM) decreed in April 2017 the implementation of secure prescription pads. The objective of this study was to evaluate the impact of this regulatory me...

Full description

Saved in:
Bibliographic Details
Published in:British journal of clinical pharmacology 2021-08, Vol.87 (8), p.3310-3319
Main Authors: Istvan, Marion, Caillet, Pascal, Rousselet, Morgane, Guerlais, Marylène, Laforgue, Edouard-Jules, Gérardin, Marie, Jolliet, Pascale, Feuillet, Fanny, Victorri-Vigneau, Caroline
Format: Article
Language:English
Subjects:
Adult
Benzodiazepines
Cohort Studies
Drug Prescriptions
Humans
Hypnotics and Sedatives
Life Sciences
Middle Aged
Zolpidem
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In recent years, zolpidem has been the subject of numerous reports of misuse, abuse and dependence. In view of these risks, the French drug agency (ANSM) decreed in April 2017 the implementation of secure prescription pads. The objective of this study was to evaluate the impact of this regulatory measure on the prescription of zolpidem and other sedative medications (zopiclone, benzodiazepines and antihistamines) in long-term users of zolpidem and associated factors.
ISSN:0306-5251
1365-2125
DOI:10.1111/bcp.14753